Carcangiu Maria Luisa, Radice Paolo, Casalini Patrizia, Bertario Lucio, Merola Marina, Sala Paolo
Department of Pathology, Anatomic Pathology A Unit, Istituto Nazionale Tumori, Milan, Italy.
Int J Surg Pathol. 2010 Feb;18(1):21-6. doi: 10.1177/1066896909332117. Epub 2009 May 14.
Although endometrial cancer (EC) represents the second most common cancer after colonic cancer in patients with Lynch syndrome (LS), the pathologic features and behavior of LS-related EC are not well recognized. ECs from 23 patients (mean age 46.2 years) with MSH2 (16), MLH1 (6), and MLH1/MSH2 (1) constitutional mutations were evaluated for histologic type, FIGO grade, FIGO stage, association with tumors in other sites, and survival. For every LS-associated tumor, 2 same-age cases from patients with no family history of LS-associated cancer were evaluated (sporadic group). In LS-associated EC there were 13 (56.5%) endometrioid (eec) and 10 (43.5%) nonendometrioid carcinomas (neec), and among the sporadic tumors there were 44 (95.7%) eec and 2 (4.3%) neec (P = .001). The eec in women with germline LS mutation had a significantly higher FIGO grade (P = .0378) and more frequent vascular invasion than the controls. The mean survival of the entire group of 23 patients with LS-related EC was 17.326 (14.066 to 20.585). Mean survival according to FIGO stage was significant (P = .010). Difference in mean survival according to age of the patient at the time of the diagnosis (patients >46 years vs <46 years) was not significant. The mean survival of the mutated patients with eec was 20.462 (17.564 to 23.359) and was not significantly different from that of the mutated patients with neec, which was 14.240 (9.119 to 19.361). Log-rank analysis showed that histology did not affect the survival. However, the hazard ratio of neec patients, although not significant, resulted higher. Mean survival of patients with a neec tumor combined with an endometrioid component (14.375 [8.084 to 20.666]) was not different from that of patients with pure neec cancers (14.250 [7.885 to 20.615]). When compared with the control population, LS-related ECs show a wider variety of histologic types; a higher frequency of neec types despite the younger age of the patients, and a higher frequency of high grades among the eec.
虽然子宫内膜癌(EC)是林奇综合征(LS)患者中仅次于结肠癌的第二大常见癌症,但LS相关EC的病理特征和行为尚未得到充分认识。对23例(平均年龄46.2岁)患有MSH2(16例)、MLH1(6例)和MLH1/MSH2(1例)基因胚系突变的患者的EC进行了组织学类型、国际妇产科联盟(FIGO)分级、FIGO分期、与其他部位肿瘤的相关性及生存率评估。对于每例LS相关肿瘤,评估2例无LS相关癌症家族史的同龄患者(散发性组)。在LS相关EC中,有13例(56.5%)为子宫内膜样癌(eec),10例(43.5%)为非子宫内膜样癌(neec);在散发性肿瘤中,有44例(95.7%)为eec,2例(4.3%)为neec(P = 0.001)。携带胚系LS突变的女性的eec具有显著更高的FIGO分级(P = 0.0378),且血管侵犯比对照组更常见。23例LS相关EC患者的总体平均生存期为17.326(14.066至20.585)。根据FIGO分期的平均生存期具有显著性差异(P = 0.010)。根据诊断时患者年龄(>46岁与<46岁)的平均生存期差异不显著。eec突变患者的平均生存期为20.462(17.564至23.359),与neec突变患者的平均生存期14.240(9.119至19.361)无显著差异。对数秩分析显示组织学不影响生存率。然而,neec患者的风险比虽不显著,但较高。伴有子宫内膜样成分的neec肿瘤患者的平均生存期(14.375 [8.084至20.666])与纯neec癌患者的平均生存期(14.250 [7.885至20.615])无差异。与对照人群相比,LS相关EC表现出更多样化的组织学类型;尽管患者年龄较轻,但neec类型的频率较高,且eec中高级别频率较高。